Castle Biosciences Stock Analysis

Castle Stock Analysis Notes

About 93.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.07. Some equities with similar Price to Book (P/B) outperform the market in the long run. Castle Biosciences recorded a loss per share of 0.19. The entity had not issued any dividends in recent years. Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. The company was founded in 2007 and is headquartered in Friendswood, Texas. Castle Biosciences operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 482 people. For more info on Castle Biosciences please contact Derek Maetzold at 866 788 9007 or go to https://castlebiosciences.com.

Castle Biosciences Investment Alerts

Castle Biosciences Upcoming and Recent Events

Castle Largest EPS Surprises

View All Earnings Estimates

Castle Biosciences Environmental, Social, and Governance (ESG) Scores

Castle Stock Institutional Investors

Note, although Castle Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Castle Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 471.2 M.

Castle Profitablity

The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.32) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.32.

Management Efficiency

Castle Biosciences has return on total asset (ROA) of (0.018) % which means that it has lost $0.018 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.012) %, meaning that it created substantial loss on money invested by shareholders. Castle Biosciences' management efficiency ratios could be used to measure how well Castle Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Castle Biosciences' Return On Tangible Assets are quite stable compared to the past year. Return On Capital Employed is expected to rise to 0.02 this year, although the value of Return On Equity will most likely fall to 0.04. At this time, Castle Biosciences' Non Current Assets Total are quite stable compared to the past year. Non Currrent Assets Other is expected to rise to about 2.3 M this year, although the value of Net Tangible Assets will most likely fall to about 181.4 M.

Technical Drivers

As of the 23rd of July, Castle Biosciences shows the Standard Deviation of 2.69, mean deviation of 2.1, and Risk Adjusted Performance of (0.11). Castle Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Castle Biosciences market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Castle Biosciences is priced correctly, providing market reflects its regular price of 16.8 per share. Given that Castle Biosciences has information ratio of (0.20), we suggest you to validate Castle Biosciences's prevailing market performance to make sure the company can sustain itself at a future point.

Castle Biosciences Price Movement Analysis

Castle Biosciences Insider Trading Activities

Castle Biosciences Outstanding Bonds

Castle Biosciences Predictive Daily Indicators

Castle Biosciences Corporate Filings

Castle Biosciences Forecast Models

Castle Biosciences' time-series forecasting models are one of many Castle Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Castle Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Castle Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Castle shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Castle Biosciences. By using and applying Castle Stock analysis, traders can create a robust methodology for identifying Castle entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Castle analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Castle analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Castle Biosciences stock analysis indicators help investors evaluate how Castle Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Castle Biosciences shares will generate the highest return on investment. By understating and applying Castle Biosciences stock analysis, traders can identify Castle Biosciences position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Castle Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. If investors know Castle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Castle Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Castle Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Castle Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Castle Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.